http://groups.yahoo.com/group/no-forced-vaccination/message/9365

Baxter Files Swine Flu Vaccine Patent A Year Ahead Of Outbreak
From Lara, Health Advocate
10 July 2009
US20090060950A1 to Baxter International filed 28th August 2008

http://www.theonecl ickgroup. co.uk/news. php?start= 2760&end=2780&view=yes&id=3581#newspost

Baxter are nothing if not prepared for this 'swine flu' outbreak if the wording in this 2008 US patent application is anything to go by:

"In particular preferred embodiments the composition or
vaccine comprises more than one antigen..... such as
influenza A and influenza B in particular selected from of one
or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2,
H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1,
H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7,
H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3,
H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2,
H8N4, H14N5, H6N5, H12N5 subtypes."

"Suitable adjuvants can be selected from mineral gels,
aluminium hydroxide, surface active substances, lysolecithin,
pluronic polyols, polyanions or oil emulsions such as water in
oil or oil in water, or a combination thereof. Of course the
selection of the adjuvant depends on the intended use.
E.g. toxicity may depend on the destined subject organism
and can vary from no toxicity to high toxicity."

"Three different influenza strains, two A-strains Hiroshima
(HR, H3N2), a New Calcdonia (NC, H1N1) and a B-strain,
Malaysia (MA), were produced in Vero cell cultures. After
virus propagation the infectious virus harvest is inactivated
prior to purification. ..."

I'm feeling so much better now that I know we have such competent pharmaceutical companies, well prepared for viral outbreaks, at least a year ahead of time...

Regards

Lara

************ *
Related Links:
* Swine Flu - Lab Accident Caused 'Pandemic' Claims NEJM
John Bingham, Daily Telegraph
* Baxter - Live Bird Flu Virus Shipped To 18 Countries As Vaccine
The Right Perspective - New York City